{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T18:27:14Z","timestamp":1788028034449,"version":"build-2784847793"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100024087","name":"Theramex","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-026-01678-w","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:24:39Z","timestamp":1772245479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Current clinical practices in osteoporosis management across Italy: a survey analysis and expert opinion"],"prefix":"10.1007","volume":"21","author":[{"given":"Bruno","family":"Frediani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Gaudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Lello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"1678_CR1","unstructured":"WHO (1998) Guidelines for preclinical evaluation and clinical trials in osteoporosis"},{"issue":"1","key":"1678_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048.","volume":"4","author":"T S\u00f6zen","year":"2017","unstructured":"S\u00f6zen T, \u00d6z\u0131\u015f\u0131k L, Ba\u015faran N\u00c7 (2017) An overview and management of osteoporosis. Eur J Rheumatol 4(1):46\u201356. https:\/\/doi.org\/10.5152\/eurjrheum.2016.048","journal-title":"Eur J Rheumatol"},{"key":"1678_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-021-00969-8","volume":"17","author":"C Willers","year":"2022","unstructured":"Willers C, Norton N, Harvey NC et al (2022) Osteoporosis in Europe: a compendium of country-specific reports. Arch Osteoporos 17:23. https:\/\/doi.org\/10.1007\/s11657-021-00969-8","journal-title":"Arch Osteoporos"},{"key":"1678_CR4","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, De Beur SJ, LeBoff MS et al (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359\u20132381. https:\/\/doi.org\/10.1007\/s00198-014-2794-2","journal-title":"Osteoporos Int"},{"key":"1678_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, McCloskey EV, Johansson H et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23\u201357. https:\/\/doi.org\/10.1007\/s00198-012-2074-y","journal-title":"Osteoporos Int"},{"key":"1678_CR6","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","volume":"359","author":"SR Cummings","year":"2002","unstructured":"Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761\u20131767. https:\/\/doi.org\/10.1016\/S0140-6736(02)08657-9","journal-title":"Lancet"},{"key":"1678_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3121\/cmr.2021.1612","volume":"20","author":"N Imamudeen","year":"2022","unstructured":"Imamudeen N, Basheer A, Iqbal AM et al (2022) Management of osteoporosis and spinal fractures: contemporary guidelines and evolving paradigms. Clin Med Res 20:95\u2013106. https:\/\/doi.org\/10.3121\/cmr.2021.1612","journal-title":"Clin Med Res"},{"key":"1678_CR8","unstructured":"https:\/\/www.osteoporosis.foundation\/sites\/iofbonehealth\/files\/scope-2021\/Italy%20report.pdf"},{"key":"1678_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11739-018-1874-2","volume":"14","author":"R Nuti","year":"2019","unstructured":"Nuti R, Brandi ML, Checchia G et al (2019) Guidelines for the management of osteoporosis and fragility fractures. Intern Emerg Med 14:85\u2013102. https:\/\/doi.org\/10.1007\/s11739-018-1874-2","journal-title":"Intern Emerg Med"},{"issue":"4","key":"1678_CR10","first-page":"561","volume":"28","author":"S Adami","year":"2010","unstructured":"Adami S, Bianchi G, Brandi ML et al (2010) Validation and further development of the WHO 10-year fracture risk assessment tool in Italian postmenopausal women: project rationale and description. Clin Exp Rheumatol 28(4):561\u2013570","journal-title":"Clin Exp Rheumatol"},{"key":"1678_CR11","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s40618-023-02082-8","volume":"46","author":"G Adami","year":"2023","unstructured":"Adami G, Biffi A, Porcu G et al (2023) A systematic review on the performance of fracture risk assessment tools: FRAX, DeFRA, FRA-HS. J Endocrinol Invest 46:2287\u20132297. https:\/\/doi.org\/10.1007\/s40618-023-02082-8","journal-title":"J Endocrinol Invest"},{"key":"1678_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1137671","author":"G Corrao","year":"2023","unstructured":"Corrao G, Biffi A, Porcu G et al (2023) Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2023.1137671","journal-title":"Front Endocrinol"},{"key":"1678_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-023-01316-9","volume":"18","author":"L Cianferotti","year":"2023","unstructured":"Cianferotti L, Porcu G, Ronco R et al (2023) The integrated structure of care: evidence for the efficacy of models of clinical governance in the prevention of fragility fractures after recent sentinel fracture after the age of 50 years. Arch Osteoporos 18:109. https:\/\/doi.org\/10.1007\/s11657-023-01316-9","journal-title":"Arch Osteoporos"},{"issue":"2","key":"1678_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMp2409086","volume":"392","author":"N Napoli","year":"2025","unstructured":"Napoli N, Ebeling PR, Kiel DP (2025) Coordinating multidisciplinary care - improving outcomes after fragility fractures. N Engl J Med 392(2):109\u2013111. https:\/\/doi.org\/10.1056\/NEJMp2409086","journal-title":"N Engl J Med"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01678-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-026-01678-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01678-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:53:34Z","timestamp":1773060814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-026-01678-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1678"],"URL":"https:\/\/doi.org\/10.1007\/s11657-026-01678-w","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Agostino Gaudio reports advisory board honoraria and\/or consultancy fees from MSD, UCB Pharma, Theramex Italy, and Sandoz. Maurizio Rossini reports advisory board honoraria, consultancy fees, and\/or speaker fees from AbbVie, Eli-Lilly, ItalFarmaco, Janssen Cilag, Neopharmed-Gentili, Theramex, UCB, outside the submitted work. Bruno Frediani, Sandro Giannini, Stefano Lello, and Nicola Napoli declare that they have no conflict of interest related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"47"}}